Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 8586998Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pharmacology
- Physical Medicine & Rehabilitation
NIH Funding · FY2026
Linked Award Amount
$1.3M
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#6,904
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Luis A Martinez-lemus as a PI. Multi-PI records show the full award amount for context.
- 5R01HL181939-02R01Tissue transglutaminase as a therapeutic target for arterial stiffening and hypertension in obesity$671.9Kaward amount
- 5R01AG082413-03R01SGLT2 inhibition as a therapeutic strategy to reverse arterial stiffening in aging$603.6Kaward amount
Award organization
Organizations that administered FY2026 awards listing Luis A Martinez-lemus as a PI.
FY2026 award administered by University of Missouri-Columbia (MO).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of Missouri-Columbia
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #5701
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder
- 2026$5M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Luis A Martinez-lemus.